Harbor Capital Advisors’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-90,267
| Closed | -$1.34M | – | 747 |
|
|
2024
Q1 | $1.34M | Buy |
90,267
+17,534
| +24% | +$260K | 0.17% | 154 |
|
|
2023
Q4 | $591K | Buy |
72,733
+7,870
| +12% | +$64K | 0.11% | 220 |
|
|
2023
Q3 | $295K | Buy |
64,863
+8,522
| +15% | +$38.8K | 0.06% | 310 |
|
|
2023
Q2 | $397K | Buy |
56,341
+5,172
| +10% | +$36.4K | 0.08% | 286 |
|
|
2023
Q1 | $313K | Buy |
51,169
+14,548
| +40% | +$88.9K | 0.09% | 184 |
|
|
2022
Q4 | $234K | Sell |
36,621
-780
| -2% | -$4.98K | 0.23% | 78 |
|
|
2022
Q3 | $358K | Sell |
37,401
-2,033
| -5% | -$19.5K | 0.33% | 70 |
|
|
2022
Q2 | $435K | Sell |
39,434
-2,749
| -7% | -$30.3K | 0.33% | 72 |
|
|
2022
Q1 | $702K | Sell |
42,183
-9,357
| -18% | -$156K | 0.33% | 72 |
|
|
2021
Q4 | $984K | Buy |
+51,540
| New | +$984K | 0.36% | 75 |
|